Plus   Neg

Kier Group Trading In Line With Board's Expectations - Quick Facts

Kier Group Plc (KIE.L) issued an update on trading for the period from 15 November 2019 to 31 December 2019. The Group said trading for the period was in line with the Board's expectations.

The Group said it continues to be awarded new contracts across the markets in which it operates, including being appointed to all 20 lots of the four-year Procure Partnerships Framework in November 2019.

The Group expects to deliver a headcount reduction of approximately 1,200 by 30 June 2020 and annual cost savings of at least 60 million pounds in the financial year ending 30 June 2021. The Group is reviewing further cost optimisation opportunities.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
Follow RTT